Additionally, targeting LSD1 can enhance CD8+ T cell infiltration into tumors and boost the anti-tumor immune response through various pathways, such as increasing chemokine expression 98-100, downregulating PD-L1 33, and accumulating dsRNA 34, 95. This evidence concerns the gene CD8A and neoplasm.